Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DX25F6VWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $35,898
Award facts
- Contract value 100% obligated
- $35,897.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $35,897.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with Defense Logistics Agency Troop Support Medical, designated SPE2DX, which represents a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency and related defense health programs. The company's portfolio encompasses a broad range of pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. As the prime contractor under the SPE2DX vehicle, AmerisourceBergen supplies pharmaceutical commodities globally to support military healthcare operations, including services for the Defense Health Agency and U.S. Coast Guard. The Dupixent delivery order represents a specific tactical need for this immunosuppressive biologic medication commonly used in the treatment of atopic dermatitis and other inflammatory conditions within the military health system.
Quick answers
Who was awarded contract SPE2DX25F6VWC?
SPE2DX25F6VWC was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 26, 2025.
How much is contract SPE2DX25F6VWC worth?
The government has obligated $35,898 on SPE2DX25F6VWC.
Is contract SPE2DX25F6VWC an order under another contract?
Yes. SPE2DX25F6VWC is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6VWC competed?
The extent of competition for SPE2DX25F6VWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award